TWM
CAI

Triton Wealth Management’s Caris Life Sciences CAI Stock Holding History

Triton Wealth Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Hold
10,918
– – 0.06% 129
2026
Q1 		$206K Hold
10,918
– – 0.08% 120
2025
Q4 		$251K Buy
10,918
+413
+4% +$11.6K 0.09% 101
2025
Q3 		$327K Hold
10,505
– – 0.12% 84
2025
Q2 		$310K Buy
+10,505
New +$283K 0.13% 85

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Triton Wealth Management's CAI Position: Q2 2026 in Review

Triton Wealth Management held its Caris Life Sciences (CAI) position steady in Q2 2026 at 10,918 shares worth $189K. The position accounts for 0.06% of the portfolio, ranked #129.

Triton Wealth Management first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. The position peaked at $327K in Q3 2025. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Triton Wealth Management held 10,918 shares of Caris Life Sciences worth $189K as of Q2 2026.
  • Triton Wealth Management left its Caris Life Sciences share count unchanged in Q2 2026.
  • Caris Life Sciences made up 0.06% of Triton Wealth Management's portfolio in Q2 2026, its #129 holding.
  • Triton Wealth Management first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Triton Wealth Management's Caris Life Sciences position peaked at $327K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Triton Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.